Compare · ACCD vs SRSA
ACCD vs SRSA
Side-by-side comparison of Accolade Inc. (ACCD) and Sarissa Capital Acquisition Corp. (SRSA): market cap, price performance, sector, and recent activity on the wire.
Summary
- ACCD operates in Consumer Discretionary, while SRSA operates in Finance - the two are in different parts of the market.
- ACCD is the larger of the two at $1.18B, about 4.8x SRSA ($244.8M).
- ACCD has more recent analyst coverage (25 ratings vs 0 for SRSA).
- Company
- Accolade Inc.
- Sarissa Capital Acquisition Corp.
- Price
- $7.03+0.00%
- $10.03+0.00%
- Market cap
- $1.18B
- $244.8M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Business Services
- Business Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- 2020
- News (4w)
- 0
- 0
- Recent ratings
- 25
- 0
Accolade Inc.
Accolade, Inc. develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was founded in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
Sarissa Capital Acquisition Corp.
Sarissa Capital Acquisition Corporation does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Greenwich, Connecticut.
Latest ACCD
- Defining Wellness Centers Names Bill Morrison Chief Financial Officer
- SEC Form 15-12G filed by Accolade Inc.
- Amendment: SEC Form SCHEDULE 13D/A filed by Accolade Inc.
- SEC Form 25-NSE filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- Chief Executive Officer Singh Rajeev returned $10,429,525 worth of shares to the company (1,483,574 units at $7.03), closing all direct ownership in the company (SEC Form 4)
Latest SRSA
- SEC Form SC 13G/A filed by Sarissa Capital Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by Sarissa Capital Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by Sarissa Capital Acquisition Corp. (Amendment)
- SEC Form 15-12G filed by Sarissa Capital Acquisition Corp.
- SEC Form 25-NSE filed by Sarissa Capital Acquisition Corp.
- Sarissa Capital Acquisition Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form SC 13G filed by Sarissa Capital Acquisition Corp.
- SEC Form 10-Q filed by Sarissa Capital Acquisition Corp.
- SEC Form PRER14A filed by Sarissa Capital Acquisition Corp.
- SEC Form PRE 14A filed by Sarissa Capital Acquisition Corp.